1-2 of 2
Juan-Jose Ortega, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of Intensive Chemotherapy (CHT), Allogeneic (ALLO) or Autologous (AUTO) Stem Cell Transplantation (SCT) as Post-Remission Treatment for Children with Very High-Risk Acute Lymphoblastic Leukemia (VHR-ALL). Final Results of the PETHEMA ALL-93 Trial.

Josep-Maria Ribera, PhD, Juan-Jose Ortega, MD, Albert Oriol, MD, Pilar Bastida, MD, Carlota Calvo, MD, Jose-María Perez-Hurtado, MD, Maria-Elvira González-Valentin, MD, Vicky Martin-Reina, MD, Antonio Molines, MD, Fernando Ortega-Rivas, MD, Maria-Pilar Queipo, MD, Concepción Rivas, MD, Izaskun Egurbide, MD, Inmaculada Heras, MD, Concepción Poderos, MD, Eva Martínez-Revuelta, MD, Jose-Maria Guinea, MD, Eloy del Potro, MD, Guillermo Deben, MD
Journal: Blood
Blood (2005) 106 (11): 173.
https://doi.org/10.1182/blood.V106.11.173.173
Published: 2005
Journal Articles

Comparison of Intensive Chemotherapy (CHT), Allogeneic (ALLO) or Autologous (AUTO) Stem Cell Transplantation (SCT) as Post-Remission Treatment for Adult Patients with High-Risk Acute Lymphoblastic Leukemia (HR-ALL). Final Results of the PETHEMA ALL-93 Trial.

Josep-Maria Ribera, MD, Albert Oriol, MD, Concepcion Bethencourt, MD, Ricardo Parody, MD, Jesus-Maria Hernandez-Rivas, MD, Maria-Jose Moreno, MD, Eloy Del Potro, MD, Mar Tormo, MD, Concepcion Rivas, MD, Joan Besalduch, MD, Miguel-Angel Sanz, MD, Jesus Arias, MD, Javier Fernandez-Calvo, MD, Jose-Maria Moraleda, MD, Javier Bueno, MD, Evarist Feliu, MD, Juan-Jose Ortega, MD
Journal: Blood
Blood (2004) 104 (11): 2731.
https://doi.org/10.1182/blood.V104.11.2731.2731
Published: 2004